EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...
Medscape6h
GLP-1 Prescribing Decisions: Compounded or Brand-Name?
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
verywellhealth1d
Bupivacaine vs. Lidocaine: A Pharmacist Explains What You Need to Know
Learn more about common anesthesia medicines bupivacaine and lidocaine, including their benefits, risks, differences, and ...
AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
AbbVie Inc.’s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., ...
Row erupts as doctors call to BAN Lemsip because 'it doesn't work' - but some insist it's the ONLY thing that eases a blocked nose
Health experts have argued that UK customers are being hoodwinked by the drug firms behind the 'useless' medicines - which include Sudafed, Lemsip and Beechams.
CNET3d
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...